{
  "ptid_time": "014_S_4668_2012-07-26",
  "img_path": "/data/qiuhui/data/adni/images/014_S_4668/2012-07-26/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 101,845 mm³, 164.4% above the reference mean. With a Z-score of 3.94 (100.0th percentile), this represents profound enlargement; whole brain volume measures 1,196,210 mm³, 10.8% above the reference mean. With a Z-score of 1.40 (92.0th percentile), this represents mild enlargement; entorhinal cortex volume measures 4,772 mm³, 16.4% above the reference mean. With a Z-score of 1.11 (86.7th percentile), this represents mild enlargement; fusiform gyrus volume measures 20,211 mm³, 7.3% above the reference mean. With a Z-score of 0.62 (73.3th percentile), this represents normal volume ; middle temporal gyrus volume measures 23,118 mm³, 8.3% above the reference mean. With a Z-score of 0.75 (77.3th percentile), this represents normal volume . ",
  "text_data": "Age is 70.8 years. Gender is Male. Education: 20 years. Handedness: Right. Race: White. Medical history: Psychiatric; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities; Malignancy; Major Surgical Procedures. MMSE: 26.0. MoCA: 21.0. Logical Memory: 1.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.67 SUVR (profound elevated); Amyloid beta: 698.10 pg/mL (normal ); Total tau: 297.20 pg/mL (normal ); Phosphorylated tau: 33.14 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound ventricular enlargement (Z-score 3.94), which is strongly suggestive of significant brain atrophy, a hallmark of neurodegenerative disease. Despite normal Aβ levels, elevated P-tau and profound AV45 (amyloid PET) suggest underlying Alzheimer's pathology. The MMSE (26) and MoCA (21) indicate mild cognitive impairment, with MoCA being more sensitive to early deficits.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**, likely due to Alzheimer’s pathology (biomarker evidence: elevated P-tau and AV45).  \n\n**Confidence:** **High** (due to clear structural atrophy, biomarker profile, and cognitive scores consistent with MCI).  \n\n*Note: The discrepancy between normal Aβ and elevated AV45 may warrant further clarification (e.g., CSF vs. PET amyloid measures), but the overall profile strongly suggests MCI with Alzheimer's changes.*",
  "timestamp": "2025-07-25T23:57:51.887601"
}